Dorrapharma is engaged in R&D, manufacture and market of intermediates, APIs (Active Pharmaceutical Ingredients) and formulations. We own the core technologyadvantage in the professional area of bromination,enzyme/metal-catalyzed, nitration and hydrogenation, and obtain multiple core patents for invention.We stick to raising the value both for the company and customers, and strive creating more valuable product for the health of the life...
MOREWe are excited to announce that on July st, Dorra Pharmaceuticals offi...
June 3, 2024 -the Food and Drug Administration granted accelerated approval to selpercatin...
Copyright Nanjing Dorra Pharmaceutical Technology Co.,Ltd. @ 2018 China All Rights Reserved 苏ICP备12056923号-1